• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Invitae | Genelex

Invitae | Genelex

Pharmacogenetics Makes Precision Medicine Possible

  • For Patients
    • Conditions
    • Affected Drugs
    • What is PGx?
    • Resources
    • FAQs
  • For Providers
    • Conditions
    • Resources
    • Order Testing Supplies
  • Test Menu
  • Clinical Trials
  • About
    • Lab Accreditations
    • Genelex Team
    • Contact Us
  • Log In

Press Releases

logo-agena

Agena Bioscience Names Genelex as Certified Service Provider for Targeted Genetic Analysis

Genelex Blog Agena Bioscience Names Genelex as Certified Service Provider for Targeted Genetic Analysis SAN DIEGO, Calif., August 29, 2016 – Agena Bioscience today announced the successful certification of Genelex as a Certified Service Provider of the MassARRAY® technology. The MassARRAY

security

Security in the Precision Medicine Initiative

Genelex Blog Security in the Precision Medicine Initiative In the White House’s 2016 Precision Medicine Initiative (PMI) Summit, President Obama noted that one of the challenges of the PMI is concerns regarding security. Incorporating “Big Data” into medicine to see larger treatment trends

United States Department of Veterans Affairs Awards Genelex Federal Supply Schedule Contract

Genelex Blog United States Department of Veterans Affairs Awards Genelex Federal Supply Schedule Contract Pharmacogenetic testing now available to improve complex medication management for veterans at risk of avoidable hospitalizations and ER visits Seattle, WA—March 15, 2016 – Genelex, the

analytics

Genelex Announces Integration With Epic

Genelex Blog Genelex Announces Integration With Epic Pharmacogenomic clinical analytics provider connects to the U.S.’s largest electronic health record system to support the reduction of drug complications, hospitalizations and ED visits Seattle, WA—February 23, 2016 – Genelex the makers of

Genelex receives Innovative Technology Designation from Vizient, Inc. for YouScript® software that reduces ER visits & hospitalizations with improved, gene-based medication management

Genelex Blog Genelex receives Innovative Technology Designation from Vizient, Inc. for YouScript® software that reduces ER visits & hospitalizations with improved, gene-based medication management Designation recognizes the development of new solutions that benefit the health care

Genelex names Kristine Ashcraft as new CEO

Genelex Blog Genelex names Kristine Ashcraft as new CEO SEATTLE, Washington; November 23, 2015 - Genelex is pleased to announce the appointment of Kristine Ashcraft as its Chief Executive Officer. A member of the Genelex team since 2000, Kristine has been essential to the growth and

Novation awards Genelex Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software

PGx In Practice Blog Novation awards Genelex Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software IRVING, TEXAS; Aug. 4, 2015 – Novation, the nation’s largest healthcare services organization, has awarded  an agreement to Seattle-based Genelex to offer

YouScript Featured At HIMSS Interoperability Showcase

PGx In Practice Blog YouScript Featured At HIMSS Interoperability Showcase DNA Tests, Together with CDS Software, Change Course of Patient Care HIMSS 2015, Booths 5220 & 2084, Chicago (April 13, 2015) – The value of pharmacogenetic testing – which reveals how genetics affect our response

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Footer

CONTACT US

(800) 837-8362
info@genelex.com

3101 Western Ave.
Suite 100
Seattle, WA 98121

HELPFUL INFORMATION

What is PGx?
Test Menu
Conditions
Affected Drugs
FAQs
References

ABOUT GENELEX

Blog
News
Genelex Team
Lab Accreditations
Contact Us
Privacy Practices
Privacy Policy

  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • YouTube

KEEP IN TOUCH

Stay in the loop with news and updates from Genelex and be among the first to know when new tests become available.